SELLAS Life Sciences Group Inc (SLS)
1.17
-0.05
(-4.10%)
USD |
NASDAQ |
Nov 22, 16:00
1.165
0.00 (0.00%)
After-Hours: 20:00
SELLAS Life Sciences Group Free Cash Flow: -33.07M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -33.07M |
| June 30, 2024 | -32.16M |
| March 31, 2024 | -30.04M |
| December 31, 2023 | -36.91M |
| September 30, 2023 | -37.24M |
| June 30, 2023 | -33.09M |
| March 31, 2023 | -33.29M |
| December 31, 2022 | -28.31M |
| September 30, 2022 | -28.13M |
| June 30, 2022 | -28.26M |
| March 31, 2022 | -22.90M |
| December 31, 2021 | -26.02M |
| September 30, 2021 | -17.62M |
| June 30, 2021 | -15.37M |
| March 31, 2021 | -13.86M |
| December 31, 2020 | -10.42M |
| September 30, 2020 | -18.02M |
| June 30, 2020 | -18.21M |
| March 31, 2020 | -19.48M |
| December 31, 2019 | -17.64M |
| September 30, 2019 | -18.02M |
| June 30, 2019 | -28.37M |
| March 31, 2019 | -30.01M |
| December 31, 2018 | -30.42M |
| September 30, 2018 | -10.62M |
| Date | Value |
|---|---|
| June 30, 2018 | -15.84M |
| March 31, 2018 | -12.59M |
| December 31, 2017 | -10.99M |
| September 30, 2017 | -1.167M |
| June 30, 2017 | 6.011M |
| March 31, 2017 | -2.431M |
| December 31, 2016 | -11.85M |
| September 30, 2016 | -52.28M |
| June 30, 2016 | -49.58M |
| March 31, 2016 | -49.96M |
| December 31, 2015 | -48.31M |
| September 30, 2015 | -43.80M |
| June 30, 2015 | -45.43M |
| March 31, 2015 | -46.84M |
| December 31, 2014 | -45.34M |
| September 30, 2014 | -32.68M |
| June 30, 2014 | -29.63M |
| March 31, 2014 | -23.91M |
| December 31, 2013 | -29.25M |
| September 30, 2013 | -36.24M |
| June 30, 2013 | -32.33M |
| March 31, 2013 | -31.50M |
| December 31, 2012 | -20.97M |
| September 30, 2012 | -19.96M |
| June 30, 2012 | -19.21M |
Free Cash Flow Range, Past 5 Years
-37.24M
Minimum
Sep 2023
-10.42M
Maximum
Dec 2020
-25.00M
Average
-27.08M
Median
Free Cash Flow Benchmarks
| Microbot Medical Inc | -8.97M |
| Alaunos Therapeutics Inc | -11.76M |
| Galectin Therapeutics Inc | -33.68M |
| Oragenics Inc | -7.682M |
| Anavex Life Sciences Corp | -30.00M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.806M |
| Cash from Financing (Quarterly) | 19.69M |
| Free Cash Flow Per Share (Quarterly) | -0.1144 |
| Free Cash Flow Yield | -56.12% |